Next generation approach strengthens national preparedness against nuclear threats by accelerating access to time-sensitive treatments that allow for longer shelf life, simplified distribution and sel ...
According to MarketsandMarkets™, the Multiomics Market is projected to reach USD 5.70 billion by 2031 from USD 3.18 billion ...
An electronic eye implant that helped patients regain practical central vision in clinical trials has received approval for ...
Genomics company Illumina (NASDAQ:ILMN) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 9.4% ...
Key Points Interested in GeneDx Holdings Corp.? Here are five stocks we like better. GeneDx exceeded expectations in Q2, ...
BioProcess International learned about how advanced therapy developers and manufacturers are adapting to changing ...
Children’s Mercy, SN Genelab, and Xcelom join Genetic Alliance’s global laboratory network Every laboratory we add to ...
Opportunities include next-generation mRNA, viral vector and DNA platforms; needle-free, oral and nasal delivery; expanded immunisation in emerging markets; oncology and pandemic vaccines; and ...
Zacks Investment Research on MSN
Insights into Illumina (ILMN) Q2: Wall Street projections for key metrics
In its upcoming report, Illumina (ILMN) is predicted by Wall Street analysts to post quarterly earnings of $1.23 per share, reflecting an increase of 3.4% compared to the same period last year.
XDA Developers on MSN
Google just launched a $99 Gemini smart speaker, and I've never been more glad I stayed on Home Assistant
Paywalls aren't the only issue ...
Amilcar has 10 years of FinTech, blockchain, and crypto startup experience and advises financial institutions, governments, regulators, and startups. Vikki Velasquez is a researcher and writer who has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results